-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
IR delivered adjusted EPS of $0.77 (+7% Y/Y), beating Wall Street estimates of $0.74, though organic revenue declined 0.3% despite 8% total revenue growth driven primarily by acquisitions (+3.7%) and favorable FX (+4.2%). Mixed segment performance emerged, with Precision & Science Tech achieving 4% organic sales growth and 120 bps margin expansion to 30.3%, while Industrial Tech faced a 2% organic decline and 210 bps of margin compression to 26.7% due to Iranian conflict headwinds. In our view, orders performance of $1,978M (+5%) was encouraging, with book-to-bill ratios above 1.0x in both segments suggesting potential for broader sales growth participation ahead. Profitability remained under pressure as adjusted EBITDA margin compressed 140 bps to 25.4%, reflecting lower volumes and input cost inflation, with margin pressure most pronounced in IT&S where pricing failed to fully offset higher costs despite operational efficiency initiatives driving positive performance in P&ST.